These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 17503045)
1. Late spontaneous remissions in severe adult autoimmune thrombocytopenia. Simanek R; Panzer S; Lechner K; Pabinger I Ann Hematol; 2007 Oct; 86(10):705-10. PubMed ID: 17503045 [TBL] [Abstract][Full Text] [Related]
3. The course of severe autoimmune thrombocytopenia in patients not undergoing splenectomy. Sailer T; Lechner K; Panzer S; Kyrle PA; Pabinger I Haematologica; 2006 Aug; 91(8):1041-5. PubMed ID: 16885043 [TBL] [Abstract][Full Text] [Related]
4. Cyclosporin A as an immunosuppressive treatment modality for patients with refractory autoimmune thrombocytopenic purpura after splenectomy failure. Zver S; Zupan IP; Cernelc P Int J Hematol; 2006 Apr; 83(3):238-42. PubMed ID: 16720554 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of splenectomy in adult chronic immune thrombocytopenia. Zoghlami-Rintelen C; Weltermann A; Bittermann C; Kyrle PA; Pabinger I; Lechner K; Wenzl E Ann Hematol; 2003 May; 82(5):290-4. PubMed ID: 12739064 [TBL] [Abstract][Full Text] [Related]
6. Retrospective analysis of patients with idiopathic thrombocytopenic purpura from Eastern Anatolia. Kaya E; Erkurt MA; Aydogdu I; Kuku I; Ozhan O; Oner RI; Ulutas O Med Princ Pract; 2007; 16(2):100-6. PubMed ID: 17303943 [TBL] [Abstract][Full Text] [Related]
7. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab. Schweizer C; Reu FJ; Ho AD; Hensel M Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529 [TBL] [Abstract][Full Text] [Related]
8. Response to splenectomy is durable after a certain point in time in adult patients with chronic immune thrombocytopenic purpura. Johansson E; Engervall P; Landgren O; Grimfors G; Widell S; Rezai S; Björkholm M Eur J Haematol; 2006 Jul; 77(1):61-6. PubMed ID: 16573739 [TBL] [Abstract][Full Text] [Related]
9. Danazol therapy in patients with chronic idiopathic thrombocytopenic purpura: long-term results. Maloisel F; Andrès E; Zimmer J; Noel E; Zamfir A; Koumarianou A; Dufour P Am J Med; 2004 May; 116(9):590-4. PubMed ID: 15093754 [TBL] [Abstract][Full Text] [Related]
10. Splenectomy results in patients with idiopathic thrombocytopenic purpura: 10 years of experience in Turgut Ozal Medical Center. Ismet A; Irfan K; Emin K; AlI EM; Ramazan U; Mustafa B; Onur O Clin Lab Haematol; 2004 Jun; 26(3):211-4. PubMed ID: 15163320 [TBL] [Abstract][Full Text] [Related]
11. Thrombocytopenia as the presenting manifestation of sarcoidosis. Agarwal V; Pal S; Agarwal A; Gupta RK; Mishra R J Assoc Physicians India; 2002 Feb; 50():268-9. PubMed ID: 12038662 [TBL] [Abstract][Full Text] [Related]
12. A single-institution, 20-year prospective experience with an affordable Fc-receptor blockade method to treat patients with chronic, refractory autoimmune thrombocytopenic purpura. Estrada-Gómez R; Vargas-Castro O; Oropeza-Borges M; González-Carrillo ML; Pérez-Romano B; Ruiz-Argüelles GJ Rev Invest Clin; 2007; 59(6):424-7. PubMed ID: 18402333 [TBL] [Abstract][Full Text] [Related]
17. Immune thrombocytopenia: Effectiveness of frontline steroids and comparison of azathioprine, splenectomy, and rituximab as second-line treatment. Chang H; Tang TC; Hung YS; Li PL; Kuo MC; Wu JH; Wang PN Eur J Haematol; 2018 Oct; 101(4):549-555. PubMed ID: 30007087 [TBL] [Abstract][Full Text] [Related]
18. The effect of platelet autoantibodies on the course of the disease and clinical response of patients with idiopathic thrombocytopenic purpura. Sikorska A; Konopka L; Maślanka K Int J Lab Hematol; 2008 Feb; 30(1):58-64. PubMed ID: 18190469 [TBL] [Abstract][Full Text] [Related]
19. [Accessory spleen causing recurrent idiopathic thrombocytopenic purpura (case report)]. Colović M; Kostić K; Colović R; Perisić-Savić M; Milosević R Srp Arh Celok Lek; 1991; 119(11-12):335-7. PubMed ID: 17974379 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura. Vancine-Califani SM; De Paula EV; Ozelo MC; Orsi FL; Fabri DR; Annichino-Bizzacchi JM Platelets; 2008 Nov; 19(7):489-95. PubMed ID: 18979360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]